Pharma Sales Strategy & Outsourced Field Team Drive Growth
Download PDF
A targeted sales strategy optimizes field operations, sustains YOY growth, and sets a benchmark for success in the competitive allergy-immunology therapeutic area.
OUR TASK
A leading biopharma company wanted to accelerate growth for an established brand while seamlessly transitioning to an outsourced field team and preserving critical HCP relationships. Amplity stepped in, delivering a high-performing sales team and a data-driven pharma sales strategy. The result: 32% YOY sales growth, expanded patient access, and a scalable model for long-term success—proving that Amplity delivers results when it matters most.
Download PDF
The Power of This Partnership
32%
Year Over Year Sales Growth
The Ask
CLIENT
Global
Large BioPharma
Growth For Established Brand
Ensure continued success in a competitive allergy-immunology market with 2-3 years of projected growth potential.
Maintain HCP Relationships
Prevent disruptions to long-established HCP connections during the onboarding of a new sales team.
Optimize Field Team Execution
Deliver seamless performance and execution across sales operations while meeting both partnership and sales objectives.
The Approach
TOOLS
Field Team
Strategic Communication Framework
Establish a robust communication structure and sales strategy with implementation calls and weekly touchpoints with client stakeholders to ensure alignment and adaptability.
Proactive Client Collaboration
Conduct regular quarterly meetings with internal stakeholders to share insights, anticipate challenges, and refine strategies.
Sales Team Calibration
Assess team needs and make targeted adjustments to align skillsets with disease-specific expertise, ensuring a seamless transition and immediate impact.
Customer-Centric Targeting
Focus sales efforts on identifying high-value HCPs and patient profiles to facilitate appropriate prescribing practices and improve treatment outcomes.
Operational Excellence
Prioritize seamless field operations to maintain the integrity of the established brand, avoid disruptions, and deliver consistent sales growth.
The Results
OUTCOME
Business Objectives Exceeded
Operational Stability
Competitive Resilience
Impressive Growth Metrics
Delivered strong Q1 results for established brand with 19% YOY demand increase and 32% YOY sales growth in first full quarter of program.
Seamless Transition
Onboarded a new sales force without disrupting HCP relationships.
Enhanced Targeting & Pharma Sales Strategy
Improved alignment between HCPs and patient needs, resulting in treatment prescriptions.
Market Competitiveness
Countered rising competition in the allergy-immunology space by driving demand and preserving the brand's integrity and market positioning.
Scalable Success Model
Developed a replicable strategy recognized by the client as a benchmark for building high-performing teams and expanding organizational capabilities across therapeutic areas.
